Dyne Therapeutics Inc (NASDAQ: DYN): Analyst View Points To Future Growth
Dyne Therapeutics Inc (DYN) concluded trading on Wednesday at a closing price of $8.88, with 5.69 million shares of worth about $50.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -64.14% during that period and on July 09, 2025 the price saw a […]
Dyne Therapeutics Inc (NASDAQ: DYN) Loses -81.71% From High. Why That Could Change?
Currently, there are 113.63M common shares owned by the public and among those 85.23M shares have been available to trade. The company’s stock has a 5-day price change of -18.34% and -17.02% over the past three months. DYN shares are trading -75.49% year to date (YTD), with the 12-month market performance down to -63.16% lower. […]
Dyne Therapeutics Inc (DYN): A Great Stock For Handling Current Market Conditions?
Currently, there are 113.63M common shares owned by the public and among those 85.23M shares have been available to trade. The company’s stock has a 5-day price change of -26.52% and -13.67% over the past three months. DYN shares are trading -53.90% year to date (YTD), with the 12-month market performance down to -67.76% lower. […]
Dyne Therapeutics Inc (DYN): A Great Stock For Handling Current Market Conditions?
Citadel Advisors LLC recently announced the acquisition of new stake in Dyne Therapeutics Inc (NASDAQ:DYN). The institutional investor has increased its shareholding in the Healthcare company by 11.54% to 3.02 million shares with purchase of 0.31 million shares. This fresh investment now brings its stake to 4.92% valued currently at $33.44 million. In addition, BlackRock […]